Urodynamic and urethral pressure profilometry findings in women with voiding phase dysfunction treated with surgical urethrolysis.
Journal
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
ISSN: 1911-6470
Titre abrégé: Can Urol Assoc J
Pays: Canada
ID NLM: 101312644
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
medline:
7
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
ppublish
Résumé
Long-term urodynamic (UDS) and urethral pressure profilometry (UPP) parameters in women with voiding phase dysfunction following an anti-incontinence (AI) procedure have been poorly characterized. We report our 10-year UDS findings in women with voiding phase dysfunction after AI procedure, who underwent urethrolysis. We identified sequential records containing urethrolysis current procedural terminology codes over a 10-year period. Records of women with preoperative UDS were reviewed for demographics, UDS tracing, and outcomes following urethrolysis. Twenty-five women (mean age 60 years) had voiding phase dysfunction and underwent urethrolysis at a mean of 47 months (interquartile range [IQR] 12-61) after AI procedure. Preoperatively, six (24%) women required intermittent catheterization. Free uroflowmetry revealed a mean maximum peak flow (Qmax) of 9.6 ml/s (IQR 7.0-11.0), voided volume of 137 ml (IQR 81-169), and postvoid residual of 167 ml (IQR 43-288). UDS revealed a mean UPP length of 24 mm (IQR 20-27), UPP closure pressure of 78 cmH UPP may help characterize outlet parameters in women with voiding phase dysfunction following an AI procedure, who ultimately undergo urethrolysis.
Identifiants
pubmed: 37549342
pii: cuaj.8342
doi: 10.5489/cuaj.8342
pmc: PMC10657230
doi:
Types de publication
Journal Article
Langues
eng
Pagination
E374-E380Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK134989
Pays : United States
Organisme : NIDDK NIH HHS
ID : R44 DK127580
Pays : United States
Références
J Urol. 2012 Dec;188(6 Suppl):2464-72
pubmed: 23098783
Neurourol Urodyn. 2019 Nov;38(8):2224-2232
pubmed: 31432550
Curr Urol Rep. 2006 Sep;7(5):384-94
pubmed: 16959178
Int Urogynecol J Pelvic Floor Dysfunct. 2006 Sep;17(5):455-9
pubmed: 16283421
J Urol. 2017 Oct;198(4):875-883
pubmed: 28625508
Int Urogynecol J. 2016 Jan;27(1):117-22
pubmed: 26134541
J Endourol. 2014 Feb;28(2):214-8
pubmed: 24074259
Female Pelvic Med Reconstr Surg. 2019 Nov/Dec;25(6):409-414
pubmed: 29787462
Neurourol Urodyn. 2019 Jun;38(5):1322-1331
pubmed: 30912192
Neurourol Urodyn. 2019 Aug;38 Suppl 4:S59-S69
pubmed: 30311659
Arch Ital Urol Androl. 2011 Dec;83(4):207-9
pubmed: 22670320
J Urol. 2010 Apr;183(4):1450-4
pubmed: 20171657
Ultrasound Obstet Gynecol. 2021 Mar;57(3):488-492
pubmed: 32672377
World J Urol. 2015 Sep;33(9):1243-50
pubmed: 26025190
Int Urogynecol J. 2019 May;30(5):761-766
pubmed: 30083942
Eur J Obstet Gynecol Reprod Biol. 2015 Dec;195:103-107
pubmed: 26512435
Int Urogynecol J. 2020 Sep;31(9):1949-1957
pubmed: 32006069
Int Urogynecol J. 2020 Apr;31(4):679-694
pubmed: 32112158
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD003881
pubmed: 22336797
Int Urogynecol J. 2012 Apr;23(4):423-8
pubmed: 21927939
Int Braz J Urol. 2011 Jan-Feb;37(1):100-7
pubmed: 21385486
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Female Pelvic Med Reconstr Surg. 2017 May/Jun;23(3):171-176
pubmed: 28398930
Int Urol Nephrol. 2020 Feb;52(2):239-246
pubmed: 31673936